Pediatric Chronic Inflammatory Demyelinating Polyneuropathy

1

Review clinical trials related to Pediatric Chronic Inflammatory Demyelinating Polyneuropathy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

Participants needed: 30
Trial details
Phase: Phase 3Age: 2-17Biological sex: AllType: InterventionalSponsor: OctapharmaUpdated: Jun 6, 2025Locations: 6
Eligibility criteria

Age ≥2 years and ≤17 years. [+3]

Patients with previously diagnosed CIDP who lack any CIDP symptoms. [+14]